Skip to main content
PMC home page
Biophysical Journal logoLink to Biophysical Journal
. 1998 Nov;75(5):2255–2261. doi: 10.1016/S0006-3495(98)77670-2

Continuous in situ electrochemical monitoring of doxorubicin efflux from sensitive and drug-resistant cancer cells.

C Yi 1, M Gratzl 1
PMCID: PMC1299900  PMID: 9788921

Abstract

One of the least well understood problems in cancer chemotherapy is the cross-resistance of certain tumor cells to a series of chemically unrelated drugs. Multidrug resistance (MDR) can be attributed to several different biophysical processes, among them increased drug efflux. This has been found to correlate with overexpression of the cell surface 170-kDa P-glycoprotein that actively excludes cytotoxic drugs against their concentration gradient. To better understand MDR, experimental methods are needed to study drug efflux from cancer cells. Continuous measurement of efflux of nonfluorescent drugs on the same cell culture in situ, or assessing efflux from a few cells or even a single cell, is beyond the capabilities of existing technologies. In this work, a carbon fiber (CF) microelectrode is used to monitor efflux of doxorubicin from a monolayer of two cell lines: an auxotrophic mutant of Chinese hamster ovary cells, AUXB1, and its MDR subline, CHRC5. Because doxorubicin is both fluorescent and electroactive, the results could be validated against existing data obtained optically and with other techniques on the same cell lines, with good agreement found. The electrochemical detection, however, is capable of in situ monitoring with high temporal resolution and is suitable for single-cell studies.

Full Text

The Full Text of this article is available as a PDF (96.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Astier A., Doat B., Ferrer M. J., Benoit G., Fleury J., Rolland A., Leverge R. Enhancement of adriamycin antitumor activity by its binding with an intracellular sustained-release form, polymethacrylate nanospheres, in U-937 cells. Cancer Res. 1988 Apr 1;48(7):1835–1841. [PubMed] [Google Scholar]
  2. Bradley G., Juranka P. F., Ling V. Mechanism of multidrug resistance. Biochim Biophys Acta. 1988 Aug 3;948(1):87–128. doi: 10.1016/0304-419x(88)90006-6. [DOI] [PubMed] [Google Scholar]
  3. Chaney E. N., Jr, Baldwin R. P. Electrochemical determination of adriamycin compounds in urine by preconcentration at carbon paste electrodes. Anal Chem. 1982 Dec;54(14):2556–2560. doi: 10.1021/ac00251a034. [DOI] [PubMed] [Google Scholar]
  4. Daoud S. S., Juliano R. L. Modulation of doxorubicin resistance by valinomycin (NSC 122023) and liposomal valinomycin in Chinese hamster ovary cells. Cancer Res. 1989 May 15;49(10):2661–2667. [PubMed] [Google Scholar]
  5. Gottesman M. M., Hrycyna C. A., Schoenlein P. V., Germann U. A., Pastan I. Genetic analysis of the multidrug transporter. Annu Rev Genet. 1995;29:607–649. doi: 10.1146/annurev.ge.29.120195.003135. [DOI] [PubMed] [Google Scholar]
  6. Inaba M., Kobayashi H., Sakurai Y., Johnson R. K. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. Cancer Res. 1979 Jun;39(6 Pt 1):2200–2203. [PubMed] [Google Scholar]
  7. Kartner N., Shales M., Riordan J. R., Ling V. Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein. Cancer Res. 1983 Sep;43(9):4413–4419. [PubMed] [Google Scholar]
  8. Krishan A., Ganapathi R. Laser flow cytometric studies on the intracellular fluorescence of anthracyclines. Cancer Res. 1980 Nov;40(11):3895–3900. [PubMed] [Google Scholar]
  9. Marquardt D., Center M. S. Drug transport mechanisms in HL60 cells isolated for resistance to adriamycin: evidence for nuclear drug accumulation and redistribution in resistant cells. Cancer Res. 1992 Jun 1;52(11):3157–3163. [PubMed] [Google Scholar]
  10. Michelson S., Slate D. A mathematical model for the inhibition of the multidrug resistance-associated P-glycoprotein pump. Bull Math Biol. 1994 Mar;56(2):207–223. doi: 10.1007/BF02460640. [DOI] [PubMed] [Google Scholar]
  11. Miyamoto Y., Oda T., Maeda H. Comparison of the cytotoxic effects of the high- and low-molecular-weight anticancer agents on multidrug-resistant Chinese hamster ovary cells in vitro. Cancer Res. 1990 Mar 1;50(5):1571–1575. [PubMed] [Google Scholar]
  12. Spoelstra E. C., Dekker H., Schuurhuis G. J., Broxterman H. J., Lankelma J. P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines. Evidence for a saturation of active daunorubicin transport. Biochem Pharmacol. 1991 Feb 1;41(3):349–359. doi: 10.1016/0006-2952(91)90531-9. [DOI] [PubMed] [Google Scholar]
  13. Spoelstra E. C., Westerhoff H. V., Dekker H., Lankelma J. Kinetics of daunorubicin transport by P-glycoprotein of intact cancer cells. Eur J Biochem. 1992 Jul 15;207(2):567–579. doi: 10.1111/j.1432-1033.1992.tb17083.x. [DOI] [PubMed] [Google Scholar]
  14. Vichi P., Tritton T. R. Adriamycin: protection from cell death by removal of extracellular drug. Cancer Res. 1992 Aug 1;52(15):4135–4138. [PubMed] [Google Scholar]
  15. Wang J., Lin M. S., Villa V. Investigation of the adsorptive stripping voltammetric behaviour of the anticancer drugs chlorambucil and 5-fluorouracil. Analyst. 1987 Mar;112(3):247–251. doi: 10.1039/an9871200247. [DOI] [PubMed] [Google Scholar]

Articles from Biophysical Journal are provided here courtesy of The Biophysical Society

RESOURCES